Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 51 citing articles:

GDF15: A Hormone Conveying Somatic Distress to the Brain
Sam Lockhart, Vladimı́r Saudek, Stephen O’Rahilly
Endocrine Reviews (2020) Vol. 41, Iss. 4
Open Access | Times Cited: 165
Metformin in colorectal cancer: molecular mechanism, preclinical and clinical aspects
Muhamad Noor Alfarizal Kamarudin, Md. Moklesur Rahman Sarker, Jin‐Rong Zhou, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 150
The GDF15-GFRAL Pathway in Health and Metabolic Disease: Friend or Foe?
Samuel N. Breit, David A. Brown, Vicky Wang-Wei Tsai
Annual Review of Physiology (2020) Vol. 83, Iss. 1, pp. 127-151
Closed Access | Times Cited: 141
Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association (HFA), European Society of Cardiology (ESC)
Wouter C. Meijers, Antoni Bayés‐Genís, Alexandre Mebazaa, et al.
European Journal of Heart Failure (2021) Vol. 23, Iss. 10, pp. 1610-1632
Open Access | Times Cited: 117
Circulating Protein Signatures and Causal Candidates for Type 2 Diabetes
Valborg Guðmundsdóttir, Shaza B. Zaghlool, Valur Emilsson, et al.
Diabetes (2020) Vol. 69, Iss. 8, pp. 1843-1853
Open Access | Times Cited: 86
Evaluating the efficacy and mechanism of metformin targets on reducing Alzheimer’s disease risk in the general population: a Mendelian randomisation study
Jie Zheng, Min Xu, Venexia Walker, et al.
Diabetologia (2022) Vol. 65, Iss. 10, pp. 1664-1675
Open Access | Times Cited: 65
Systematic review of Mendelian randomization studies on risk of cancer
Georgios Markozannes, Afroditi Kanellopoulou, Olympia Dimopoulou, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 50
Evaluating the impact of metformin targets on the risk of osteoarthritis: a mendelian randomization study
Yan Zhang, Delong Li, Zhaohua Zhu, et al.
Osteoarthritis and Cartilage (2022) Vol. 30, Iss. 11, pp. 1506-1514
Open Access | Times Cited: 40
Beyond the 2020 guidelines on atrial fibrillation of the European society of cardiology
Giuseppe Boriani, Marco Vitolo, Deirdre A. Lane, et al.
European Journal of Internal Medicine (2021) Vol. 86, pp. 1-11
Closed Access | Times Cited: 54
Efficacy of metformin targets on cardiometabolic health in the general population and non-diabetic individuals: a Mendelian randomization study
Jie Zheng, Min Xu, Qian Yang, et al.
EBioMedicine (2023) Vol. 96, pp. 104803-104803
Open Access | Times Cited: 18
Impact of glycemic traits, type 2 diabetes and metformin use on breast and prostate cancer risk: a Mendelian randomization study
Shiu Lun Au Yeung, C. Mary Schooling
BMJ Open Diabetes Research & Care (2019) Vol. 7, Iss. 1, pp. e000872-e000872
Open Access | Times Cited: 45
Associations between potential causal factors and colorectal cancer risk: A systematic review and meta‐analysis of Mendelian randomization studies
Yunyang Deng, Lyu Wang, Junjie Huang, et al.
Journal of Digestive Diseases (2022) Vol. 23, Iss. 8-9, pp. 435-445
Closed Access | Times Cited: 26
Extended-release metformin improves cognitive impairment in frail older women with hypertension and diabetes: preliminary results from the LEOPARDESS Study
Pasquale Mone, Giuseppe Martinelli, Angela Lucariello, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 16
Evaluating the impact of AMPK activation, a target of metformin, on risk of cardiovascular diseases and cancer in the UK Biobank: a Mendelian randomisation study
Shan Luo, C. Mary Schooling, Ian Chi Kei Wong, et al.
Diabetologia (2020) Vol. 63, Iss. 11, pp. 2349-2358
Open Access | Times Cited: 37
GDF-15, a future therapeutic target of glucolipid metabolic disorders and cardiovascular disease
Qing-Ao Xiao, Qian He, Jun Zeng, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 146, pp. 112582-112582
Open Access | Times Cited: 32
Acute Exercise Increases GDF15 and Unfolded Protein Response/Integrated Stress Response in Muscle in Type 2 Diabetes
Rugivan Sabaratnam, Jonas M. Kristensen, Andreas James Thestrup Pedersen, et al.
The Journal of Clinical Endocrinology & Metabolism (2024) Vol. 109, Iss. 7, pp. 1754-1764
Closed Access | Times Cited: 4
Exploring the protective effect of metformin against sarcopenia: insights from cohort studies and genetics
Yanyan Hu, Shan Lu, Cheng Xue, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Revisiting the role of GDF15 in atherosclerosis in mouse and human
Monan Liu, Zhenghong Liu, Rui‐Xue Leng, et al.
Acta Pharmacologica Sinica (2025)
Closed Access
Using genetics to decipher the link between type 2 diabetes and cancer: shared aetiology or downstream consequence?
Emma E. Vincent, Hanieh Yaghootkar
Diabetologia (2020) Vol. 63, Iss. 9, pp. 1706-1717
Open Access | Times Cited: 31
Growth Differentiation Factor (GDF)-15 and Cardiometabolic Outcomes among Older Adults: The Atherosclerosis Risk in Communities Study
Justin B. Echouffo‐Tcheugui, Natalie Daya, Kunihiro Matsushita, et al.
Clinical Chemistry (2020) Vol. 67, Iss. 4, pp. 653-661
Open Access | Times Cited: 29
Ageing-related markers and risks of cancer and cardiovascular disease: a prospective study in the EPIC-Heidelberg cohort
Bernard Srour, Rudolf Kaaks, Theron Johnson, et al.
European Journal of Epidemiology (2021) Vol. 37, Iss. 1, pp. 49-65
Open Access | Times Cited: 26
Association between growth differentiation factor 15 levels and gestational diabetes mellitus: A combined analysis
Yicheng Lu, Song-Liang Liu, Yushan Zhang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 9
Clinical perspectives and concerns of metformin as an anti‐aging drug
Chuyao Wang, Bangwei Chen, Qian Feng, et al.
Aging Medicine (2020) Vol. 3, Iss. 4, pp. 266-275
Open Access | Times Cited: 22
The impact of growth differentiation factor 15 on the risk of cardiovascular diseases: two-sample Mendelian randomization study
Zhuo Wang, Fangkun Yang, Menghuai Ma, et al.
BMC Cardiovascular Disorders (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 21
Integrated analyses of growth differentiation factor-15 concentration and cardiometabolic diseases in humans
Susanna Lemmelä, Eleanor M. Wigmore, Christian Benner, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top